Corporate Spotlight

Telix at AdMeTech Summit on Precision Diagnosis and Treatment of Prostate Cancer

16 September 2021 – Clinical Spotlight | Telix to support and participate in AdMeTech 5th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer

Telix is delighted to announce our support for the AdMeTech 5th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer, to be held virtually from 23-25 September 2021.

We are also pleased to sponsor a session entitled: “PSMA PET/CT Imaging – Emerging Clinical Applications from a Urologic Perspective”, on Friday, 24 September 2021 at 8.28 am (EST), which will be presented by Dr. Neal Shore MD, FACS, Director & CPI at Carolina Urologic Research Center (CURC); Chief Surgical Officer and Head of Urology Research at Genesis Care USA; Founding Director at CUSP: Clinical Research Consortium, Myrtle Beach, South Carolina, with an opportunity for Q&A following the presentation.

Finally, we will be presenting an abstract entitled: “Safety of 68Ga -PSMA-11 prepared with the cold kit used in the Pivotal Lu-PSMA 617 Vision trial for selection of PSMA positive patients.”

To register for the AdMeTech 5th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer please click here.

To view the conference program please click here.

To view Telix’s accepted abstract please click here.

To return to the Telix homepage please click here.